Abstract:The recent worldwide rise in idiopathic immune and inflammatory diseases such as multiple sclerosis (MS) and inflammatory bowel diseases (IBD) has been linked to Western society-based changes in lifestyle and environment. These include decreased exposure to sunlight/UVB light and subsequent impairment in the production of vitamin D, as well as dysbiotic changes in the makeup of the gut microbiome. Despite their association, it is unclear if there are any direct links between UVB light and the gut microbiome. In this study we investigated whether exposing the skin to Narrow Band Ultraviolet B (NB-UVB) light to increase serum vitamin D levels would also modulate the makeup of the human intestinal microbiota. The effects of NB-UVB light were studied in a clinical pilot study using a healthy human female cohort (n = 21). Participants were divided into those that took vitamin D supplements throughout the winter prior to the start of the study (VDS+) and those who did not (VDS−). After three NB-UVB light exposures within the same week, the serum 25(OH)D levels of participants increased on average 7.3 nmol/L. The serum response was negatively correlated to the starting 25-hydroxy vitamin D [25(OH)D] serum concentration. Fecal microbiota composition analysis using 16S rRNA sequencing showed that exposure to NB-UVB significantly increased alpha and beta diversity in the VDS− group whereas there were no changes in the VDS+ group. Bacteria from several families were enriched in the VDS− group after the UVB exposures according to a Linear Discriminant Analysis (LDA) prediction, including Lachnospiracheae, Rikenellaceae, Desulfobacteraceae, Clostridiales vadinBB60 group, Clostridia Family XIII, Coriobacteriaceae, Marinifilaceae, and Ruminococcus. The serum 25(OH)D concentrations showed a correlation with the relative abundance of the Lachnospiraceae, specifically members of the Lachnopsira and Fusicatenibacter genera. This is the first study to show that humans with low 25(OH)D serum levels display overt changes in their intestinal microbiome in response to NB-UVB skin exposure and increases in 25(OH)D levels, suggesting the existence of a novel skin-gut axis that could be used to promote intestinal homeostasis and health.Clinical Trial Registration: <a href="https://clinicaltrials.gov">clinicaltrials.gov</a>, NCT03962673. Registered 23 May 2019 – Retrospectively registered, <a href="https://clinicaltrials.gov/ct2/show/NCT03962673?term=NCT03962673&rank=1">https://clinicaltrials.gov/ct2/show/NCT03962673?term=NCT03962673&rank=1</a>.

Daily full spectrum light exposure prevents food allergy-like allergic diarrhea by modulating vitamin D3 and microbiota composition

Fecal microbiota transplantation alleviates food allergy in neonatal mice via the PD-1/PD-L1 pathway and change of the microbiota composition

Altered fecal microbiota composition associated with food allergy in infants.

Early intervention and prevention of allergic diseases

Exploring the Molecular Mechanisms Underlying the Protective Effects of Microbial SCFAs on Intestinal Tolerance and Food Allergy

Fecal microbiota transplantation as a new way for OVA-induced atopic dermatitis of juvenile mice

Early-life Risk Factors for Food Allergy: Dietary and Environmental Factors Revisited.

Intermittent fasting protects against food allergy in a murine model via regulating gut microbiota

Gut Microbiota and Fecal Microbiota Transplantation in Patients with Food Allergies: A Systematic Review

Low FODMAP Diet Relieves Visceral Hypersensitivity and is Associated with Changes in Colonic Microcirculation in Water Avoidance Mice Model.

Microbiota therapy acts via a regulatory T cell MyD88/RORγt pathway to suppress food allergy

The microbial origins of food allergy

IBD functions as a double-edged sword for food allergy in BALB/c mice model

Tremella fuciformis polysaccharides alleviate induced atopic dermatitis in mice by regulating immune response and gut microbiota

Fecal Microbiota Transplantation Alleviates Allergic Rhinitis via CD4+ T Cell Modulation Through Gut Microbiota Restoration

Microbiome Composition and Its Impact on the Development of Allergic Diseases

Gut microbiota restoration through fecal microbiota transplantation: a new atopic dermatitis therapy

Probiotic strains alleviated OVA-induced food allergy in mice by regulating the gut microbiota and improving the level of indoleacrylic acid in fecal samples

Human Fecal Microbiota Transplantation Reduces the Susceptibility to Dextran Sulfate Sodium-Induced Germ-Free Mouse Colitis

Skin Exposure to Narrow Band Ultraviolet (UVB) Light Modulates the Human Intestinal Microbiome

Oral administration of egg ovalbumin allergen induces dysregulation of tryptophan metabolism in sensitized Balb/c mice